Skip to content Skip to footer

India Supplies 30% of Global Generic Medicines: MoS Health Anupriya Patel

According to Minister of State for Health Anupriya Patel, India’s position as a global pharmaceutical powerhouse is strengthening, with the country supplying roughly 30% of the world’s generic medications. 

Known as the “pharmacy of the world,” India has established a solid reputation for producing high-quality, low-cost medications, ensuring access to inexpensive healthcare in both developed and developing countries. The country’s pharmaceutical sector is vital to global health supply chains, especially in terms of providing essential pharmaceuticals at cheap pricing. 

To further increase affordability, the government encourages the use of generic pharmaceuticals produced domestically. Doctors have been directed to prescribe generics in accordance with national medical guidelines, with the goal of reducing patients’ out-of-pocket healthcare expenses. 

Regulatory agencies are also improving quality controls through improved market surveillance systems to guarantee that safety and efficacy standards are met. 

With continuous policy backing and rising global demand, India is anticipated to strengthen its position in the generic medicines industry while also contributing considerably to global health security. 

Source – News On AIR 

Leave a comment

According to Minister of State for Health Anupriya Patel, India’s position as a global pharmaceutical powerhouse is strengthening, with the country supplying roughly 30% of the world’s generic medications. 

Known as the “pharmacy of the world,” India has established a solid reputation for producing high-quality, low-cost medications, ensuring access to inexpensive healthcare in both developed and developing countries. The country’s pharmaceutical sector is vital to global health supply chains, especially in terms of providing essential pharmaceuticals at cheap pricing. 

To further increase affordability, the government encourages the use of generic pharmaceuticals produced domestically. Doctors have been directed to prescribe generics in accordance with national medical guidelines, with the goal of reducing patients’ out-of-pocket healthcare expenses. 

Regulatory agencies are also improving quality controls through improved market surveillance systems to guarantee that safety and efficacy standards are met. 

With continuous policy backing and rising global demand, India is anticipated to strengthen its position in the generic medicines industry while also contributing considerably to global health security. 

Source – News On AIR